BITS Pilani Institutional Repository: Browsing DSpace

Browsing by Author Mahesh, R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 57 to 76 of 112 < previous next >

Issue Date	Title	Author(s)
2010-05	Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats	Mahesh, R.
2014	Effects of adhatoda vasica leaf extract in depression coâ€‘morbid with alloxanâ€‘induced diabetes in mice	Mahesh, R.
2013-11	Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: Modulation of hypothalamic–pituitary–adrenal axis activity and brain-derived neurotrophic factor level	Mahesh, R.
2013-04	Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage	Mahesh, R.
2014-08	Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy	Mahesh, R.
2015-02	Evaluation of Anti-depressant and Analgesic- Like Activity of Ondansetron in Rodents Model of Co-morbid Pain and Depression	Mahesh, R.; Yadav, Sushil
2015-02	Evaluation of Anti-depressant and Analgesic- Like Activity of Ondansetron in Rodents Model of Co-morbid Pain and Depression	Mahesh, R.; Yadav, Sushil
2014	Evaluation of Antioxidant Potential of Barleria prionitis Leaf and Stem	Mahesh, R.
2012	Evaluation of anti‑diabetic activity of methanolic extract from the bark of Atalantia monophylla (Linn.) in alloxan‑induced diabetic mice	Mahesh, R.
2015-05	Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents	Mahesh, R.
2015	Insignificant in vitro falcipain-2 inhibitory activity of novel 2-(4-(substituted benzoyl) piperazine-1-yl)-N-phenylacetamide derivatives	Mahesh, R.
2015	Insignificant in vitro falcipain‑2 inhibitory activity of novel 2‑(4‑(substituted benzoyl) piperazine‑1‑yl)‑N‑phenylacetamide derivatives	Mahesh, R.
2014-04	Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice	Mahesh, R.
2012-06	Ligand-Based Design, Synthesis, and Pharmacological Evaluation of 3-Methoxyquinoxalin-2-carboxamides as Structurally Novel Serotonin Type-3 Receptor Antagonists	Mahesh, R.
2015-10	Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention	Mahesh, R.
2004-10	Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists	Mahesh, R.
2005-06	Microwave-assisted solvent-free synthesis of 3-[(4-substituted piperazin-1-yl)alkyl] imidazo[2,1-b][1,3]benzothiazol-2(3H)-ones as serotonin3 (5-HT3) receptor antagonists	Mahesh, R.
2017-12	Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model	Mahesh, R.
2013	Neuro-pharmacological evaluation of structurally novel 5-hydroxytryptamine type 3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) for its anxiolytic potential	Mahesh, R.
2016-09	Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats	Mahesh, R.

Showing results 57 to 76 of 112 < previous next >